News > Main page

News

Press Release: OWL and BIOSFER join forces to increase the use of metabolomics in the diagnosis and treatment of diseases

01/19/2021

Press Release: OWL and BIOSFER join forces to increase the use of metabolomics in the diagnosis and treatment of diseases

The two firms, both representative of diagnostic solutions based on metabolomic technology, have signed a collaboration agreement to increase R&D in the sector.
OWL will contribute its know-how in the creation of non-invasive diagnosis techniques for patients with non-alcoholic steatohepatitis (NASH).
The goal is to encourage the use of metabolomic technology in the research and development of appropriate tools to support the diagnosis and treatment of different conditions.

Check filed news

OWL is a trading name of
ONE WAY LIVER, S.L
Parque Tecnológico de Bizkaia
Edificio 502 - Planta 0
48160 Derio - Bizkaia - Spain
Phone:
+34 94 431 85 40

With this web OWL intends to provide users with information to better understand their health and their diagnosed illnesses. You should consult with a
qualified physician for diagnosis and for answers to your personal questions/circunstances.
Last update: 01/19/2021

With the collaboration of: